Our mission is ‘To improve patients' access to medical care through evidence - worldwide".
Pharmerit puts its team of leading scientists, clinicians, methodologists, strategists, pricing and reimbursement specialists and academicians to the task of understanding, shaping and communicating the value of health care interventions. We conduct Health Economic and Outcomes Research to inform local, national, and international decision makers in pharmaceutical, biotechnology, device, and diagnostic companies, government bodies and private organizations involved in the delivery and financing of health care.
Whether you need to evaluate the value of a new treatment in early stage of development, assess the unmet needs for a product's new indication, determine the quality of life impact of a new therapy, design or interpret the results of a clinical trial, or define a reimbursement strategy, chances are that our team, with over 125 years of combined experience, has successfully addressed this or a very similar problem numerous times in the past.
Whatever the unique and specific challenges you face, you will find in working with Pharmerit a team of researchers dedicated to find customized, authoritative and timely answers that have practical and actionable implications for you and other decision makers.